Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Urobilinogen is a biochemical compound that results from the reduction of bilirubin, a substance produced during the breakdown of red blood cells. This process occurs primarily in the intestines, where bacteria act on stercobilinogen, converting it into urobilinogen. The presence of urobilinogen in feces is significant as it contributes to the characteristic brown color of stool, which is primarily due to the oxidation of urobilinogen to stercobilin. The measurement of urobilinogen levels in feces can provide valuable insights into a patient's liver function and overall health. Abnormal levels of urobilinogen may indicate various medical conditions; for instance, decreased levels can occur in cases of biliary obstruction, where the flow of bile is impeded, or as a result of the use of certain antibiotics that disrupt the normal intestinal flora, thereby affecting the bacterial conversion process. Understanding these dynamics is crucial for healthcare professionals when interpreting laboratory results related to liver function and gastrointestinal health.
© Copyright 2026 Coding Ahead. All rights reserved.
Urobilinogen testing is indicated for the evaluation of various conditions related to liver function and biliary health. The following are specific indications for performing this test:
The procedure for measuring urobilinogen in feces involves several key steps to ensure accurate results. The following outlines the procedural steps:
After the urobilinogen test is completed, the patient may not require any specific post-procedure care, as the test is non-invasive and does not involve any significant risks. However, it is important for healthcare providers to discuss the results with the patient, explaining any abnormal findings and their potential implications for liver and gastrointestinal health. Follow-up testing or additional diagnostic procedures may be recommended based on the results and the patient's overall clinical picture.
| Short Descr | ASSAY OF FECES/UROBILINOGEN | Medium Descr | ASSAY OF UROBILINOGEN FECES QUANTITATIVE | Long Descr | Urobilinogen, feces, quantitative | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Medium Descriptor changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.